Breastfeeding moms with malaria: do drugs reach baby?
NCT ID NCT05676645
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks how the malaria drug artemether-lumefantrine passes from a breastfeeding mother into her breastmilk and then into her nursing infant. Researchers will take blood and milk samples from 30 mother-infant pairs in Uganda over two weeks. The goal is to understand drug exposure in infants, which could lead to better dosing guidelines for breastfeeding women.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
artemether-lumefantrine
What this could lead to
If successful, this study could provide data to help doctors choose safe and effective malaria treatments for breastfeeding women and their babies.
What could go wrong
This is a small observational study (30 pairs) that only measures drug levels, not health outcomes. Results may not apply to other malaria drugs or regions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA FALCIPARUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Infectious Diseases Institute
Kampala, Kampala, 22418, Uganda